Abdul Mannan Baig (MBBS; Ph.D.)
Abdul Mannan Baig (MBBS; Ph.D.)
Scientist and Researcher St Georg klinik Bad Abiling Germany
No verified email - Homepage
Cited by
Cited by
Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanisms
AM Baig, A Khaleeq, U Ali, H Syeda
ACS chemical neuroscience 11 (7), 995-998, 2020
Neurological manifestations in COVID‐19 caused by SARS‐CoV‐2
AM Baig
CNS neuroscience & therapeutics 26 (5), 499, 2020
Chronic COVID syndrome: Need for an appropriate medical terminology for long‐COVID and COVID long‐haulers.
AM Baig
Journal of medical virology 93 (5), 2021
Deleterious outcomes in long-hauler COVID-19: the effects of SARS-CoV-2 on the CNS in chronic COVID syndrome
AM Baig
ACS chemical neuroscience 11 (24), 4017-4020, 2020
Potential neuroinvasive pathways of SARS‐CoV‐2: Deciphering the spectrum of neurological deficit seen in coronavirus disease‐2019 (COVID‐19)
AM Baig, EC Sanders
Journal of medical virology 92 (10), 1845-1857, 2020
Updates on what ACS reported: emerging evidences of COVID-19 with nervous system involvement
AM Baig
ACS Chemical Neuroscience 11 (9), 1204-1205, 2020
In Vitro Efficacies of Clinically Available Drugs against Growth and Viability of an Acanthamoeba castellanii Keratitis Isolate Belonging to the T4 Genotype
AM Baig, J Iqbal, NA Khan
Antimicrobial agents and chemotherapy 57 (8), 3561-3567, 2013
Pathogenesis of amoebic encephalitis: are the amoebae being credited to an ‘inside job’done by the host immune response?
AM Baig
Acta tropica 148, 72-76, 2015
Computing the effects of SARS-CoV-2 on respiration regulatory mechanisms in COVID-19
AM Baig
ACS Chemical Neuroscience 11 (16), 2416-2421, 2020
Novel chemotherapeutic strategies in the management of primary amoebic meningoencephalitis due to Naegleria fowleri
AM Baig, NA Khan
CNS neuroscience & therapeutics 20 (3), 289, 2014
Primary Amoebic Meningoencephalitis: Neurochemotaxis and Neurotropic Preferences of Naegleria fowleri
AM Baig
ACS chemical neuroscience 7 (8), 1026-1029, 2016
Acanthamoeba and bacteria produce antimicrobials to target their counterpart
J Iqbal, R Siddiqui, NA Khan
Parasites & vectors 7, 1-6, 2014
Counting the neurological cost of COVID-19
AM Baig
Nature Reviews Neurology 18 (1), 5-6, 2022
Combined drug therapy in the management of granulomatous amoebic encephalitis due to Acanthamoeba spp., and Balamuthia mandrillaris
H Kulsoom, AM Baig, R Siddiqui, NA Khan
Experimental parasitology 145, S115-S120, 2014
Evidence of a M1-muscarinic GPCR homolog in unicellular eukaryotes: featuring Acanthamoeba spp bioinformatics 3D-modelling and experimentations
AM Baig, HR Ahmad
Journal of Receptors and Signal Transduction 37 (3), 267-275, 2017
Differential receptor dependencies: expression and significance of muscarinic M1 receptors in the biology of prostate cancer
AM Baig, NA Khan, V Effendi, Z Rana, HR Ahmad, F Abbas
Anti-cancer drugs 28 (1), 75-87, 2017
Traced on the Timeline: Discovery of Acetylcholine and the Components of the Human Cholinergic System in a Primitive Unicellular Eukaryote Acanthamoeba spp.
AM Baig, Z Rana, S Tariq, S Lalani, HR Ahmad
ACS chemical neuroscience, 2017
Neurological manifestations of COVID-19
D Kanwar, AM Baig, M Wasay
JPMA. The Journal of the Pakistan Medical Association 70 (5 (Suppl 3)), S101, 2020
Tackling infection owing to brain-eating amoeba
AM Baig, NA Khan
Acta tropica 142, 86-88, 2015
Primary amoebic meningoencephalitis: amoebicidal effects of clinically approved drugs against Naegleria fowleri.
AM Baig, HK Huma Kulsoom, NA Khan
The system can't perform the operation now. Try again later.
Articles 1–20